These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 9252139)
1. Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts. Guido M; Rugge M; Leandro G; Fiel IM; Thung SN Hepatology; 1997 Aug; 26(2):310-4. PubMed ID: 9252139 [TBL] [Abstract][Full Text] [Related]
2. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Carpino G; Morini S; Ginanni Corradini S; Franchitto A; Merli M; Siciliano M; Gentili F; Onetti Muda A; Berloco P; Rossi M; Attili AF; Gaudio E Dig Liver Dis; 2005 May; 37(5):349-56. PubMed ID: 15843085 [TBL] [Abstract][Full Text] [Related]
3. Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study. Carpino G; Franchitto A; Morini S; Corradini SG; Merli M; Gaudio E Ital J Anat Embryol; 2004; 109(4):225-38. PubMed ID: 15717457 [TBL] [Abstract][Full Text] [Related]
4. Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapy. Khan MA; Poulos JE; Brunt EM; Li L; Solomon H; Britton RS; Bacon BR; Di Bisceglie AM Hepatogastroenterology; 2001; 48(37):212-5. PubMed ID: 11268968 [TBL] [Abstract][Full Text] [Related]
5. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C. Russo MW; Firpi RJ; Nelson DR; Schoonhoven R; Shrestha R; Fried MW Liver Transpl; 2005 Oct; 11(10):1235-41. PubMed ID: 16184580 [TBL] [Abstract][Full Text] [Related]
6. GFAP expression in the liver as an early marker of stellate cells activation. Morini S; Carotti S; Carpino G; Franchitto A; Corradini SG; Merli M; Gaudio E Ital J Anat Embryol; 2005; 110(4):193-207. PubMed ID: 16536051 [TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy. Sakaida I; Nagatomi A; Hironaka K; Uchida K; Okita K Am J Gastroenterol; 1999 Feb; 94(2):489-96. PubMed ID: 10022652 [TBL] [Abstract][Full Text] [Related]
8. Relationship between plasma cells and hepatic stellate cells in autoimmune hepatitis. Brandão DF; Ramalho FS; Martinelli AL; Zucoloto S; Ramalho LN Pathol Res Pract; 2010 Dec; 206(12):800-4. PubMed ID: 20926203 [TBL] [Abstract][Full Text] [Related]
9. Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C. Carotti S; Morini S; Corradini SG; Burza MA; Molinaro A; Carpino G; Merli M; De Santis A; Muda AO; Rossi M; Attili AF; Gaudio E Liver Transpl; 2008 Jun; 14(6):806-14. PubMed ID: 18508359 [TBL] [Abstract][Full Text] [Related]
10. Hepatic stellate cell activation and hepatic fibrosis in children with type 1 autoimmune hepatitis: an immunohistochemical study of paired liver biopsies before treatment and after clinical remission. Maia JM; Maranhão Hde S; Sena LV; Rocha LR; Medeiros IA; Ramos AM Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):264-9. PubMed ID: 20009940 [TBL] [Abstract][Full Text] [Related]
11. Hepatic expression of c-Myb in chronic human liver disease. Kitada T; Seki S; Nakatani K; Kawada N; Kuroki T; Monna T Hepatology; 1997 Dec; 26(6):1506-12. PubMed ID: 9397991 [TBL] [Abstract][Full Text] [Related]
12. Hepatic stellate cells in biopsies from liver allografts with acute rejection. Bilezikçi B; Demirhan B; Sar A; Arat Z; Karakayali H; Haberal M Transplant Proc; 2006 Mar; 38(2):589-93. PubMed ID: 16549182 [TBL] [Abstract][Full Text] [Related]
15. Hepatic stellate cells in hepatitis C patients: relationship with the development of interstitial fibrosis in renal allografts. Ozdemir BH; Bilezikçi B; Haberal M Transplant Proc; 2009 Sep; 41(7):2838-40. PubMed ID: 19765451 [TBL] [Abstract][Full Text] [Related]
16. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation. Gawrieh S; Papouchado BG; Burgart LJ; Kobayashi S; Charlton MR; Gores GJ Liver Transpl; 2005 Oct; 11(10):1207-13. PubMed ID: 16184568 [TBL] [Abstract][Full Text] [Related]
17. [Effect of pegylated interferon beta-1a therapy on the liver fibrosis in chronic hepatitis C: a semi-quantitative analysis]. Rao HY; Li J; Zhang LF; Chen HY; Zhu LM; Wei L; Sun Y; Wang H Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):96-100. PubMed ID: 18353212 [TBL] [Abstract][Full Text] [Related]
18. The value of alpha-SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: a histopathological and immunohistochemical study. Akpolat N; Yahsi S; Godekmerdan A; Yalniz M; Demirbag K Histopathology; 2005 Sep; 47(3):276-80. PubMed ID: 16115228 [TBL] [Abstract][Full Text] [Related]
19. Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis C. Cisneros L; Londoño MC; Blasco C; Bataller R; Miquel R; Bruguera M; Ginès P; Rimola A Liver Transpl; 2007 Jul; 13(7):1017-27. PubMed ID: 17600343 [TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease. Correlation with histology and viral hepatitis. Akyol G; Erdem O; Yilmaz G Saudi Med J; 2005 Dec; 26(12):1904-10. PubMed ID: 16380770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]